Astrana Health (NASDAQ:ASTH) Stock Price Expected to Rise, Needham & Company LLC Analyst Says

Astrana Health (NASDAQ:ASTH) had its price target hoisted by Needham & Company LLC from $30.00 to $41.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s target price indicates a potential upside of 13.64% from the stock’s previous close.

Several other brokerages have also commented on ASTH. Zacks Research raised shares of Astrana Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 11th. Robert W. Baird lifted their price objective on shares of Astrana Health from $37.00 to $40.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 15th. BTIG Research lifted their price objective on shares of Astrana Health from $40.00 to $50.00 and gave the stock a “buy” rating in a research report on Friday. Truist Financial lifted their price objective on shares of Astrana Health from $37.00 to $38.00 and gave the stock a “buy” rating in a research report on Friday, March 13th. Finally, Weiss Ratings raised shares of Astrana Health from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Six equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, Astrana Health currently has a consensus rating of “Moderate Buy” and an average target price of $38.14.

Astrana Health Stock Up 2.4%

Astrana Health stock opened at $36.08 on Friday. Astrana Health has a fifty-two week low of $18.08 and a fifty-two week high of $36.20. The stock has a market cap of $2.01 billion, a PE ratio of 78.44 and a beta of 0.98. The firm’s 50-day simple moving average is $27.38 and its 200 day simple moving average is $25.67. The company has a debt-to-equity ratio of 1.25, a quick ratio of 1.40 and a current ratio of 1.40.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Thursday, May 7th. The company reported $0.74 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.45. Astrana Health had a net margin of 0.71% and a return on equity of 5.59%. The business had revenue of $965.10 million for the quarter, compared to analysts’ expectations of $949.21 million. During the same period in the previous year, the company earned $0.42 earnings per share. The firm’s revenue for the quarter was up 55.6% compared to the same quarter last year. Research analysts predict that Astrana Health will post 1.44 EPS for the current fiscal year.

Institutional Trading of Astrana Health

Hedge funds and other institutional investors have recently modified their holdings of the business. Signaturefd LLC raised its position in shares of Astrana Health by 57.9% in the fourth quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after purchasing an additional 388 shares during the period. GAMMA Investing LLC raised its position in shares of Astrana Health by 144.7% in the fourth quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after purchasing an additional 871 shares during the period. Strs Ohio bought a new stake in shares of Astrana Health in the fourth quarter valued at approximately $40,000. Covestor Ltd raised its position in shares of Astrana Health by 210.6% in the third quarter. Covestor Ltd now owns 3,233 shares of the company’s stock valued at $92,000 after purchasing an additional 2,192 shares during the period. Finally, Tower Research Capital LLC TRC raised its position in shares of Astrana Health by 323.3% in the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after purchasing an additional 3,517 shares during the period. Institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.